Market research for market analysis for severe hemorrhage control (extremity, junctional and truncal)

Ended Awarded Last action

Contract number
W81XWH18F0066
Awardee
Awarding agency
Obligated
$587,667

Award facts

Opportunity
Contract value 100% obligated
$587,666.63 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 3 offers Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Frederick, MD 21702, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00010 · The purpose of this task order is to perform market research and develop an independent assessment that can be utilized by the defense health agency (DHA)… -$15,724
Change Order P00009 $0
Change Order P00008 $0
Change Order P00007 · DVC is requesting a no cost period of performance extension to give the government adequate time to review the AOA study plan and to give DVC adequate time to… $0
Other Administrative Action P00006 · A non-cost period of performance extension to give the government adequate time to review the AOA study plan and to give DVC adequate time to finalize the… $0
Exercise an Option P00005 · Services to perform market research and develop an independent assessment summarizing research findings, host an industry workshop event, conduct an AOA study… $225,903
Supplemental Agreement for work within scope P00004 · Base period - support services; admin MOD changing the receiving entity from usamma to usammda. $0
Other Administrative Action P00003 · Lifting stop work order $0
Supplemental Agreement for work within scope P00002 · Stop work order 4-11-18 $0
Other Administrative Action P00001 · Admin MOD to fix award / funding and errors in the PWS. -$0
Original award $377,488
Show all 11

About this award

Written by GovTribe AI ·

This is a firm fixed-price delivery order awarded by the Department of the Army Medical Command to Dynport Vaccine Company LLC, a subsidiary of General Dynamics Corporation. The contract, with a potential value of $587,666.63, is for market research and analysis to support severe hemorrhage control (extremity, junctional, and truncal) product development. The contract is part of the Medical Product Research and Development multiple award indefinite-delivery, indefinite-quantity (IDIQ) contract vehicle. Dynport Vaccine Company provides a range of research, development, manufacturing, and testing services to support biopharmaceutical products targeting infectious diseases. This award does not utilize a set-aside.

Quick answers

Who was awarded contract W81XWH18F0066?

W81XWH18F0066 was awarded to Dynport Vaccine Company LLC by Medical Command (Department of the Army) on March 20, 2018.

How much is contract W81XWH18F0066 worth?

The government has obligated $587,667 on W81XWH18F0066.

Is contract W81XWH18F0066 an order under another contract?

Yes. W81XWH18F0066 is a delivery order under W81XWH15D0037, an indefinite delivery contract, on Medical Product Research and Development.

Was contract W81XWH18F0066 competed?

The extent of competition for W81XWH18F0066 was full and open competition. The government received 3 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login